Eliana Ojeda

Eliana Ojeda

Auto-generated profile, based on publicly available information

Eliana Ojeda

Departamento de Medicina Humana, Facultad de Ciencias de la Salud, Universidad Andina del Cusco

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2011 in Menopause
Verified
Journal Article
Closed access
JBJuan E. Blümel
Juan E. Blümel
PCPeter Chedraui
Peter Chedraui
GBGerman Baron
German Baron
EBEmma Belzares
Emma Belzares
ABAscanio Bencosme
Ascanio Bencosme
SVSoledad Vallejo
Soledad Vallejo
The aim of this study was to determine vasomotor symptom (VMS) prevalence, duration, and impact on quality of life in middle-aged women using a validated menopausal tool. The Menopause Rating Scale (MRS) and an itemized questionnaire containing personal sociodemographic data were used to examine 8,373 women aged 40 to 59 years from 22 healthcare centers in 12 Latin American countries. Less than half (48.8%) of all women studied were postmenopausal, 14.7% used hormone therapy (HT), 54.5% presented VMS of any degree, and 9.6% presented severe/bothersome symptoms. The rate of VMS (any degree) significantly increased from one menopausal stage to the next. HT users presented more VMS (any degree) than did nonusers (58.6% vs 53.8%, P = 0.001). When surgical postmenopausal women were compared, non-HT users displayed a higher prevalence of severe VMS (16.1% vs 9.0%, P = 0.0001). The presence of VMS of any degree was related to a more impaired quality of life (higher total MRS score; odds ratio, 4.7; 95% CI, 4.1-5.3). This effect was even higher among women presenting severe VMS. Logistic regression analysis determined that the presence of severe psychological/urogenital symptoms (MRS), lower educational level, natural perimenopause-postmenopause status, nulliparity, surgical menopause, and living at high altitude were significant risk factors for severe VMS. HT use was related to a lower risk. A second regression model determined that surgical menopause, intense psychological/urogenital symptoms, and a history of psychiatric consultation were factors related to severe VMS persisting into the late postmenopausal stage (5 or more years). In this Latin American middle-aged series, VMS prevalence was high, persisting into the late postmenopausal phase in a high rate and severely impairing quality of life. HT use was related to a lower risk of severe VMS.

1 August 2012 in Maturitas
Verified
Journal Article
Closed access
JBJuan E. Blümel
Juan E. Blümel
ACAntonio Cano
Antonio Cano
EMEdward Mezones-Holguín
Edward Mezones-Holguín
GBGermán Barón
Germán Barón
ABAscanio Bencosme
Ascanio Bencosme
PCPeter Chedraui
Peter Chedraui

1 July 2006 in Menopause
Verified
Journal Article
Closed access
JBJuan E. Blümel
Juan E. Blümel
PCPeter Chedraui
Peter Chedraui
ACAndrés Calle
Andrés Calle
RBRoberto Bocanera
Roberto Bocanera
EDEduardo Depiano
Eduardo Depiano
SLSelva Lima
Selva Lima
To assess the age at menopause (AM) in Latin America urban areas. A total of 17,150 healthy women, aged 40 to 59 years, accompanying patients to healthcare centers in 47 cities of 15 Latin American countries, were surveyed regarding their age, educational level, healthcare coverage, history of gynecological surgery, smoking habit, presence of menses, and the use of contraception or hormone therapy at menopause. The AM was calculated using logit analysis. The mean age of the entire sample was 49.4 +/- 5.5 years. Mean educational level was 9.9 +/- 4.5 years, and the use of hormone therapy and oral contraception was 22.1% and 7.9%, respectively. The median AM of women in all centers was 48.6 years, ranging from 43.8 years in Asuncion (Paraguay) to 53 years in Cartagena de Indias (Colombia). Logistic regression analysis determined that women aged 49 living in cities at 2,000 meters or more above sea level (OR = 2.0, 95% CI: 1.4-2.9, P < 0.001) and those with lower educational level (OR = 1.9, 95% CI: 1.3-2.8, P < 0.001) or living in countries with low gross national product (OR = 2.1, 95% CI: 1.5-2.9, P < 0.001) were more prone to an earlier onset of menopause. The AM varies widely in Latin America. Lower income and related poverty conditions influence the onset of menopause.

1 November 2009 in Menopause
Verified
Journal Article
Closed access
JBJuan E. Blümel
Juan E. Blümel
PCPeter Chedraui
Peter Chedraui
GBGerman Baron
German Baron
EBEmma Belzares
Emma Belzares
ABAscanio Bencosme
Ascanio Bencosme
KTKonstantinos Tserotas
Konstantinos Tserotas
The purpose of this study was to assess the prevalence of sexual dysfunction (SD) and associated risk factors among middle-aged Latin American women using one validated instrument. The Female Sexual Function Index (FSFI) was applied to 7,243 healthy women aged 40 to 59 years who were users of 19 healthcare systems from 11 Latin American countries. An itemized questionnaire containing personal and partner sociodemographic data was also filled out. Mean ± SD age of surveyed women was 49.0 ± 5.7 years, with 11.6 years of schooling on average. There were 55.1% of women who were married, 46.8% who were postmenopausal, 14.1% who used hormonal therapy (HT), and 25.6% who were sexually inactive. Among those who were active (n = 5,391), the mean ± SD total FSFI score was 25.2 ± 5.9 and 56.8% of them presented SD (FSFI total score ≤26.55), with a prevalence varying from 21.0% to 98.5% depending on the center. Centers were grouped in terciles (according to mean ± SD prevalence). The tercile with higher SD prevalence (86.4%) compared with that with lower SD prevalence (32.2%) had significantly older women (49.5 ± 5.3 vs 48.0 ± 5.6 y) with a higher rate of vaginal dryness (60.4% vs 40.8%) and older partners (53.0 ± 6.9 vs 50.2 ± 7.5 y). Similarly, there was a significantly higher rate of married (68.5% vs 63.1%), postmenopausal (49.7% vs 39.3%), and HT-using women (23% vs 9.2%). There were no differences in regard to their health perception, history of oophorectomy, rape, and partner SD rate (27% vs 26.2%). The total FSFI score was significantly lower in the tercile with higher SD prevalence (22.0 ± 5.0 vs 27.5 ± 5.4). Logistic regression analysis was used to determine the odds ratios (95% CIs) for the main risk factors associated with SD among those who were sexually active: bad lubrication, 3.86 (3.37-4.43); use of alternative menopausal therapies, 2.13 (1.60-2.84); partner SD, 1.89 (1.63-2.20); older women (>48 y), 1.84 (1.61-2.09); bladder problems, 1.47 (1.28-1.69); HT use, 1.39 (1.15-1.68); negative perception of female health status, 1.31 (1.05-1.64); and being married, 1.22 (1.07-1.40). Protective factors were higher educational level (women), partner faithfulness, and access to private healthcare. The prevalence of SD in this middle-aged Latin American series was found to be high, varying widely in different populations. A decrease in vaginal lubrication was the most important associated risk factor. Differences in the prevalence of risk factors among the studied groups, several of which are modifiable, could explain the variation of SD prevalence observed in this study.

1 December 2008 in Maturitas
Verified
Journal Article
Closed access
PCPeter Chedraui
Peter Chedraui
JBJuan E. Blümel
Juan E. Blümel
GBGerman Baron
German Baron
EBEmma Belzares
Emma Belzares
ABAscanio Bencosme
Ascanio Bencosme
KTKonstantinos Tserotas
Konstantinos Tserotas

1 May 2016 in Menopause
Verified
Journal Article
Closed access
JBJuan E. Blümel
Juan E. Blümel
JFJuan Fica
Juan Fica
PCPeter Chedraui
Peter Chedraui
EMEdward Mezones-Holguín
Edward Mezones-Holguín
MZMaría C. Zuñiga
María C. Zuñiga
SASócrates Aedo
Sócrates Aedo
The aim of the study was to evaluate the association between sedentary lifestyle and the severity of menopausal symptoms and obesity in middle-aged women. The Menopause Rating Scale, the Goldberg Anxiety and Depression Scale, and the Athens Insomnia Scale were administered to 6,079 Latin American women aged 40 to 59 years. Sedentary lifestyle was defined as fewer than three weekly, 30-minute periods of physical activity. Sedentary women had more severe menopausal symptoms (total Menopause Rating Scale score: 9.57 ± 6.71 vs 8.01 ± 6.27 points, P < 0.0001) and more depressive symptoms (Goldberg), anxiety (Goldberg), and insomnia (Athens Scale) compared with non-sedentary women. They also had greater mean waist circumference (86.2 ± 12.3 vs 84.3 ± 1.8 cm, P < 0.0001) and a higher prevalence of obesity (20.9% vs 14.3%, P < 0.0001). Logistic regression analysis showed that both obesity (odds ratio [OR] 1.52; 95% CI, 1.32-1.76) and severe menopausal symptoms (OR 1.28; 95% CI, 1.06-1.53), including insomnia and depressive mood, were positively associated with a sedentary lifestyle. Having a stable partner (OR 0.85; 95% CI, 0.76-0.96), using hormone therapy (OR 0.75; 95% CI, 0.64-0.87) and having a higher educational level (OR 0.66; 95% CI, 0.60-0.74) were negatively related to sedentary lifestyle. There was a high prevalence of sedentary lifestyle in this middle-aged Latin American female sample which was associated with more severe menopausal symptoms and obesity.